The bill, known as the Emerson Kate Cole Act, amends existing school medication policies to enhance the management of students with asthma and severe allergies. It requires school districts to adopt policies that allow for the self-administration of asthma and anaphylaxis medications, with necessary authorizations from parents or legal guardians. Key provisions include the requirement for school employees to call 911 if Epinephrine is administered to a student and to notify the parent or legal guardian if a student experiences a possible allergic reaction. Additionally, the bill mandates annual training for teachers and school employees on recognizing anaphylaxis and administering Epinephrine, with specific guidelines for the content and method of training.

The bill also updates statutory language and references, ensuring that school districts are informed about their liability regarding the self-administration of medications. It specifies that a licensed physician can prescribe necessary medications to the school district, which must maintain a minimum supply of Epinephrine injectors and inhalers at each school site. The act is set to take effect on July 1, 2025, and includes a declaration of emergency for its immediate implementation.